AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to ...

AM CET Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune ...

If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...

“Don’t get too excited,” President Marcos said as he dismissed rumors about his death as “highly exaggerated.” The rumors were sparked by what Malacañang described as “discomfort” that landed the ...

Neuropathy may be an early symptom of ATTR-CM. Explore treatments and lifestyle tips that may help you maintain or improve ...

Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2025 results on Jan. 29, before market open. In the last reported quarter, earnings of $5.79 per share beat the Zacks Consensus ...

CSI Pharmacy provides in-home infusion therapy and clinical care for patients living with rare and chronic conditions, ...

All patients with autoimmune hemolytic anemia in a small study initially achieved remission, though two eventually relapsed, ...

A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...

DelveInsight’s Generalized Myasthenia Gravis Market Insights report includes a comprehensive understanding of current treatment practices, emerging generalized myasthenia gravis drugs, market share of ...

(MENAFN- GetNews) The Key Myasthenia Gravis Companies in the market include - Alexion, AstraZeneca, Argenx, Novartis, Alpine Immune Science, Toleranzia, Cabaletta Bio ...

New York, USA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | ...